Your browser doesn't support javascript.
loading
Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIII.
Reding, M T; Ng, H J; Poulsen, L H; Eyster, M E; Pabinger, I; Shin, H-J; Walsch, R; Lederman, M; Wang, M; Hardtke, M; Michaels, L A.
Affiliation
  • Reding MT; University of Minnesota Medical Center, Minneapolis, MN, USA.
  • Ng HJ; Department of Haematology, Singapore General Hospital, Singapore.
  • Poulsen LH; Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Aarhus, Denmark.
  • Eyster ME; Penn State Hershey Medical Center, Hershey, PA, USA.
  • Pabinger I; Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Shin HJ; Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea.
  • Walsch R; Bayer Vital GmbH, Leverkusen, Germany.
  • Lederman M; Bayer, Whippany, NJ, USA.
  • Wang M; Bayer, Whippany, NJ, USA.
  • Hardtke M; Bayer Pharma AG, Berlin, Germany.
  • Michaels LA; Bayer, Whippany, NJ, USA.
J Thromb Haemost ; 15(3): 411-419, 2017 03.
Article in En | MEDLINE | ID: mdl-27992112

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyethylene Glycols / Factor VIII / Hemophilia A / Hemorrhage Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Child / Humans / Male / Middle aged Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2017 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyethylene Glycols / Factor VIII / Hemophilia A / Hemorrhage Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Child / Humans / Male / Middle aged Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2017 Document type: Article Affiliation country: Country of publication: